Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
7.64B
Market cap7.64B
Price-Earnings ratio
46.86
Price-Earnings ratio46.86
Dividend yield
Dividend yield
Average volume
324.37K
Average volume324.37K
High today
$285.75
High today$285.75
Low today
$280.00
Low today$280.00
Open price
$284.62
Open price$284.62
Volume
395.56K
Volume395.56K
52 Week high
$343.12
52 Week high$343.12
52 Week low
$228.40
52 Week low$228.40

Stock Snapshot

As of today, Bio-Rad Laboratories Class A(BIO) shares are valued at $282.44. The company's market cap stands at 7.64B, with a P/E ratio of 46.86.

On 2026-06-19, Bio-Rad Laboratories Class A(BIO) stock traded between a low of $280.00 and a high of $285.75. Shares are currently priced at $282.44, which is +0.9% above the low and -1.2% below the high.

Bio-Rad Laboratories Class A(BIO) shares are trading with a volume of 395.56K, against a daily average of 324.37K.

During the past year, Bio-Rad Laboratories Class A(BIO) stock moved between $228.40 at its lowest and $343.12 at its peak.

During the past year, Bio-Rad Laboratories Class A(BIO) stock moved between $228.40 at its lowest and $343.12 at its peak.

BIO News

Simply Wall St 13h
How Stronger Results and Institutional Selling At Bio-Rad Laboratories Has Changed Its Investment Story

Recently, Bio-Rad Laboratories reported year-over-year growth in both revenue and net profit while institutional investors, led by First Eagle Investment, signi...

How Stronger Results and Institutional Selling At Bio-Rad Laboratories Has Changed Its Investment Story

Analyst ratings

57%

of 7 ratings
Buy
28.6%
Hold
57.1%
Sell
14.3%

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.